LUM/IVA
ApprovedTerminated 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cystic Fibrosis
Conditions
Cystic Fibrosis
Trial Timeline
Jun 1, 2016 → Aug 1, 2017
NCT ID
NCT02823470About LUM/IVA
LUM/IVA is a approved stage product being developed by Vertex Pharmaceuticals for Cystic Fibrosis. The current trial status is terminated. This product is registered under clinical trial identifier NCT02823470. Target conditions include Cystic Fibrosis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04235140 | Phase 3 | Completed |
| NCT03125395 | Phase 3 | Completed |
| NCT02823470 | Approved | Terminated |
| NCT02797132 | Phase 3 | Completed |
Competing Products
20 competing products in Cystic Fibrosis